Editas Appoints Dan Ory as Chief Medical Officer

Evidence Company disclosure · Effective September 8, 2026 · Discovery September 9, 2026 · Importance 3/5 · Direction Neutral Summary Editas Medicine appointed Dan Ory, M.D., chief medical officer effective September 8, 2026. He will oversee clinical-development strategy and operations as EDIT-401 approaches clinical development…